scholarly journals A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness

2021 ◽  
pp. 1-9
Author(s):  
Kerstin Willenborg ◽  
Emilio Avallone ◽  
Hannes Maier ◽  
Thomas Lenarz ◽  
Susan Busch

<b><i>Objective:</i></b> The Cochlear™ Osia® System (Osia) is an active transcutaneous bone conduction implant system intended for patients with conductive and mixed hearing loss but can also be used in cases of single-sided deafness (SSD) for the contralateral routing of signal (CROS). The Osia implant is placed subcutaneously under the intact skin behind the ear with the piezoelectric actuator connected to an osseointegrated BI300 implant – a titanium screw used for a 2-stage Baha surgery – on the mastoid. The external processor is magnetically attached to the subcutaneous implant receiver coil. As the Osia has recently been CE certified and is new on the market, with limited patient outcome data for SSD available, the objective of this study was the evaluation of surgical procedure, audiological results, and patient satisfaction for the Osia in SSD patients. <b><i>Study Design:</i></b> In a prospective, monocentric clinical observation study, 6 patients (18 years of age or older) with SSD and bone conduction thresholds pure tone average 0.5, 1, 2, and 4 kHz ≤25 dB HL on the contralateral side were implanted with an Osia. Analysis of clinical outcome data with respect to surgical technique, adverse events, audiological measurement, and subjective benefit for SSD patients was conducted. Audiological measurements performed included hearing thresholds, sound field thresholds, word recognition scores (WRS; in %) in quiet, and speech recognition thresholds in noise (in dB SNR). All tests were performed unaided and aided with the Osia. The subjective benefit with the Osia was determined by using 2 questionnaires; the Abbreviated Profile of Hearing Aid Benefit (APHAB) and the Bern Benefit in Single-Sided Deafness (BBSSD). <b><i>Results:</i></b> Preliminary results indicate a straightforward surgical procedure with a low rate of complications and an improvement in speech perception in quiet, listening performance in everyday situations and patient satisfaction. However, in one of 6 subjects, a revision surgery had to be performed. <b><i>Conclusion:</i></b> Provided that SSD patients are open for CROS hearing, they can benefit from the Osia by reduced head shadow effects and better speech recognition. Special caution should be given to the skin at the site of implantation to avoid complications.

2014 ◽  
Vol 35 (6) ◽  
pp. 1017-1025 ◽  
Author(s):  
Jolien Desmet ◽  
Kristien Wouters ◽  
Marc De Bodt ◽  
Paul Van de Heyning

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Alexander M. Huber ◽  
Bernd Strauchmann ◽  
Marco D. Caversaccio ◽  
Wilhelm Wimmer ◽  
Thomas Linder ◽  
...  

2011 ◽  
Vol 51 (3) ◽  
pp. 194-199 ◽  
Author(s):  
Jacob Rasmussen ◽  
Steen Østergaard Olsen ◽  
Lars Holme Nielsen

2020 ◽  
Author(s):  
Assen Koitschev ◽  
Nadine Berger ◽  
Antje Ulmer ◽  
Peter Amrhein ◽  
Christiane Koitschev

2021 ◽  
Author(s):  
A Koitschev ◽  
N Berger ◽  
A Ulmer ◽  
P Amrhein ◽  
C Koitschev

2020 ◽  
Vol 25 (5) ◽  
pp. 263-275 ◽  
Author(s):  
Ann-Charlotte Persson ◽  
Sabine Reinfeldt ◽  
Bo Håkansson ◽  
Cristina Rigato ◽  
Karl-Johan Fredén Jansson ◽  
...  

Background: The bone conduction implant (BCI) is an active transcutaneous bone conduction device where the transducer has direct contact to the bone, and the skin is intact. Sixteen patients have been implanted with the BCI with a planned follow-up of 5 years. This study reports on hearing, quality of life, and objective measures up to 36 months of follow-up in 10 patients. Method: Repeated measures were performed at fitting and after 1, 3, 6, 12, and 36 months including sound field warble tone thresholds, speech recognition thresholds in quiet, speech recognition score in noise, and speech-to-noise thresholds for 50% correct words with adaptive noise. Three quality of life questionnaires were used to capture the benefit from the intervention, appreciation from different listening situations, and the ability to interact with other people when using the BCI. The results were compared to the unaided situation and a Ponto Pro Power on a soft band. The implant functionality was measured by nasal sound pressure, and the retention force from the audio processor against the skin was measured using a specially designed audio processor and a force gauge. Results: Audiometry and quality of life questionnaires using the BCI or the Ponto Pro Power on a soft band were significantly improved compared to the unaided situation and the results were statistically supported. There was generally no significant difference between the two devices. The nasal sound pressure remained stable over the study period and the force on the skin from the audio processor was 0.71 ± 0.22 N (mean ± 1 SD). Conclusion: The BCI improves the hearing ability for tones and speech perception in quiet and in noise for the indicated patients. The results are stable over a 3-year period, and the patients subjectively report a beneficial experience from using the BCI. The transducer performance and contact to the bone is unchanged over time, and the skin area under the audio processor remains without complications during the 3-year follow-up.


2019 ◽  
Vol 58 (12) ◽  
pp. 956-963
Author(s):  
Se-Joon Oh ◽  
Eui-Kyung Goh ◽  
Sung-Won Choi ◽  
Seokhwan Lee ◽  
Hyun-Min Lee ◽  
...  

Author(s):  
Ji Hyeon Lee ◽  
Young Joon Seo

As the technology advances and bone conduction implant (BCI) use increases, implantable bone conduction hearing aids are regarded as a treatment method for single-sided deafness (SSD) and their efficacy on SSD must be discussed. Therefore, we organized the problems of SSD and types of implantable bone conduction hearing aids and explained their effectiveness in the treatment of SSD in terms of changes in 1) speech recognition in a noisy environment, 2) sound localization, 3) subjective satisfaction as assessed by questionnaire, and 4) tinnitus. Although bone conduction hearing aids do not significantly improve localization ability in SSD, they increase the ability to listen under noise, increasing subjective satisfaction. Tinnitus improvement was also reported. The active forms of BCI like MED-EL BONEBRIDGE®2 and Cochlear Osia®2 have been developed well. Based on these technological developments and effects, bone conduction hearing aids would be a good option for treatment option of SSD.


Sign in / Sign up

Export Citation Format

Share Document